Phio Pharmaceuticals Corp (PHIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.99M
Last updated: Nov 17, 2026 at 4:10 PM ET
Phio Pharmaceuticals Corp (PHIO) Statistics
Phio Pharmaceuticals (PHIO) has a market cap of $8.99M. Its share count is up 142.29% from a year earlier. It holds $13.00M more cash than debt, 144.56% of its market cap.
Total Valuation
| Market Cap | $8.99M |
|---|---|
| Latest price (Nov 17, 2026) | $0.72 |
Key Dates
The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 44.83% over 52 weeks and trades 22.58% below its 50-day average.
| Beta (1Y) | 1.12 |
|---|---|
| 52-Week Change | -44.83% |
| 1-Month Change | -17.46% |
| 3-Month Change | -37.63% |
| 6-Month Change | -32.34% |
| 5-Year Change | -99.53% |
| 10-Year Change | -100.00% |
| Total Return (1Y) | -44.83% |
| Total Return (3Y CAGR) | -57.24% |
| Total Return (5Y CAGR) | -65.58% |
| Max Drawdown (1Y) | -56.53% |
| Max Drawdown (3Y) | -94.99% |
| Sharpe Ratio (1Y) | -0.76 |
| Correlation with SPY (1Y) | 0.21 |
| 50-Day Average | $0.93 |
| 200-Day Average | $1.07 |
| 52-Week Range | $0.72 to $1.88 |
| RSI (14 Days) | 27.3 |
| Average Volume (20 Days) | 63.68K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 8.39x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 8.39x |
|---|---|
| Quick Ratio | 8.39x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -102.40% and return on assets is -90.19% over the last 12 months.
| Return on Equity (ROE) | -102.40% |
|---|---|
| Return on Assets (ROA) | -90.19% |
| ROA (5Y Average) | -84.62% |
| ROIC (5Y Average) | -36.15% |
Scores
PHIO has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$1.00K |
| Operating Income | -$13.47M |
| Pretax Income | -$12.93M |
| Net Income | -$12.90M |
| Reported EPS (TTM) | -$1.21 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 88.05% of the $14.31M in total assets.
| Cash and Equivalents | $13.00M |
|---|---|
| Total Debt | $0 |
| Net Cash | $13.00M |
| Net Cash Per Share | $1.12 |
| Working Capital | $12.59M |
| Shareholder Equity | $12.60M |
| Book Value Per Share | $1.08 |
| Total Assets | $14.31M |
| Total Liabilities | $1.71M |
Balance sheet as of Jun 30, 2026.
Cash Flow
| Operating Cash Flow | -$12.20M |
|---|---|
| FCF Per Share | -$1.05 |
| Depreciation and Amortization | $5.00K |
Trailing 12 months through Jun 30, 2026.
Dividends and Yields
PHIO does not pay a dividend.
| Buyback Yield | -137.09% |
|---|---|
| Shareholder Yield | -137.09% |
Stock Splits
The last split was a 1-for-9 reverse split on Jul 5, 2024.
| Last Split Date | Jul 5, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:9 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About PHIO
What is PHIO's market cap?
Phio Pharmaceuticals has a market cap of $8.99M.
How many shares of PHIO are outstanding?
Phio Pharmaceuticals has 11.62M shares outstanding. The count is up 142.29% from a year earlier.
Does PHIO pay a dividend?
No. Phio Pharmaceuticals does not pay a dividend.
How much debt does PHIO have?
Phio Pharmaceuticals has $0 of total debt and $13.00M of cash and equivalents, a net cash position of $13.00M.
PHIO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors